Combined Versus Monotherapy Anti-Complement and Anti-Vascular Endothelial Growth Factor Intravitreal Injections for Age-Related Macular Degeneration: Safety Outcomes in the Real World
Publication date: Available online 5 November 2026 Source: Ophthalmology Retina Author(s): Houri Esmaeilkhanian, Conrad Dorflinger, Caroline Wang, Philip P. Storey, Hasenin Al-khersan, Kenneth C. Fan, Samuel Minaker, Mathew MacCumber, Kevin Quinn, Diana Holcomb, Charles C. Wykoff, Edward H. Wood
Combined Versus Monotherapy Anti-Complement and Anti-Vascular Endothelial Growth Factor Intravitreal Injections for Age-Related Macular Degeneration: Safety Outcomes in the Real World. // Ophthalmology Retina. – URL: https://www.sciencedirect.com/science/article/pii/S246865302600566X?dgcid=rss_sd_all
Combined Versus Monotherapy Anti-Complement and Anti-Vascular Endothelial Growth Factor Intravitreal Injections for Age-Related Macular Degeneration: Safety Outcomes in the Real World. Ophthalmology Retina. https://www.sciencedirect.com/science/article/pii/S246865302600566X?dgcid=rss_sd_all
“Combined Versus Monotherapy Anti-Complement and Anti-Vascular Endothelial Growth Factor Intravitreal Injections for Age-Related Macular Degeneration: Safety Outcomes in the Real World.” Ophthalmology Retina.
@article{article60856,
title = {Combined Versus Monotherapy Anti-Complement and Anti-Vascular Endothelial Growth Factor Intravitreal Injections for Age-Related Macular Degeneration: Safety Outcomes in the Real World},
journal = {Ophthalmology Retina},
url = {https://www.sciencedirect.com/science/article/pii/S246865302600566X?dgcid=rss_sd_all}
}
Abstract Purpose To compare the efficacy of intravitreal dexamethasone (DEX) implant‐based regimen versus ranibizumab‐based regimen for managing retinal exudation and complications in stage 3 Coats' disease. Methods Thirty‐seven eyes...
Abstract Foundation models are rapidly emerging as a major development in ophthalmic artificial intelligence, largely because they can achieve strong downstream performance with fewer labelled images than conventional supervised models,...
Abstract Purpose To evaluate intraretinal fluid (IRF) volume dynamics after switching from aflibercept 2 mg to faricimab in eyes with diabetic macular oedema (DME), stratified by prior response to aflibercept. Methods This retrospective...